DLIN-MC4-DMA

CAS No. 1226909-66-5

DLIN-MC4-DMA( —— )

Catalog No. M37350 CAS No. 1226909-66-5

DLIN-MC4-DMA is a lipid membrane and is a potential nucleic acid carrier.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 75 In Stock
10MG 123 In Stock
25MG 250 In Stock
50MG 415 In Stock
100MG 641 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DLIN-MC4-DMA
  • Note
    Research use only, not for human use.
  • Brief Description
    DLIN-MC4-DMA is a lipid membrane and is a potential nucleic acid carrier.
  • Description
    DLin-M-C4-DMA (Compound MC4) is a cationic lipid. DLin-M-C4-DMA can be used for delivery of nucleic acids.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1226909-66-5
  • Formula Weight
    656.12
  • Molecular Formula
    C44H81NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(OC(CCCCN(C)C)=O)(CCCCCCCC/C=C\C/C=C\CCCCC)CCCCCCCC/C=C\C/C=C\CCCCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Steven M. Ansell, et al. Lipids and lipid nanoparticle formulations for delivery of nucleic acids. Patent US10166298. 2019-01-01.
molnova catalog
related products
  • (+)-JNJ-A07

    (+)-JNJ-A07 is a pan-serotypic dengue virus inhibitor that targets NS3-NS4B interaction with high potency. (+)-JNJ-A07 has antiviral activity and can be used to study dengue virus infections.

  • HLM006474

    HLM006474 is a pan inhibitor of E2F. This inhibits E2F4 DNA-binding (IC50: 29.8 μM in A375 cells).HLM006474 causes the viability of both SCLC and NSCLC lines (IC50 ranging from 15 to 75 μM). HLM006474 displays little activities against E2F4 DNA-binding in A375 cells at 10 and 20 μM, apparently inhibits E2F4 DNA-binding at 40 μM, and increasingly suppresses the effect at 60 and 80 μM concentrations.

  • VRK-IN-1

    VRK-IN-1 is a potent and selective inhibitor of [cowpox-associated kinase 1 (VRK1)], suitable for researching neurological disorders.